← All trials
NCT04014218
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 8, 2019
- Primary completion
- Sep 30, 2019
- Completion date
- Jan 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Moscow Regional Research and Clinical Institute Moniki n.a. M.F. VladimirskiyLead sponsor
- I.M. Sechenov First Moscow State Medical UniversityCollaborator
- Moscow Regional Research and Clinical Institute Moniki n.a. M.F. VladimirskiyReponsible party - principal investigator
- Moscow Regional Research and Clinical Institute Moniki n.a. M.F. VladimirskiyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.